Susquehanna International Group
IMVT icon

Susquehanna International Group’s Immunovant IMVT Stock Holding History

Susquehanna International Group’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.6M Buy
465,900
+298,600
+178% +$7.73M ﹤0.01% 2896
2025
Q4 		$4.25M Buy
167,300
+97,100
+138% +$2.17M ﹤0.01% 4281
2025
Q3 		$1.13M Sell
70,200
-24,300
-26% -$393K ﹤0.01% 7050
2025
Q2 		$1.51M Sell
94,500
-90,300
-49% -$1.37M ﹤0.01% 6422
2025
Q1 		$3.16M Buy
184,800
+85,700
+86% +$1.79M ﹤0.01% 4557
2024
Q4 		$2.45M Buy
99,100
+40,200
+68% +$1.14M ﹤0.01% 4854
2024
Q3 		$1.68M Buy
58,900
+17,300
+42% +$510K ﹤0.01% 5647
2024
Q2 		$1.1M Sell
41,600
-177,000
-81% -$5.03M ﹤0.01% 6356
2024
Q1 		$7.06M Sell
218,600
-7,900
-3% -$288K ﹤0.01% 3111
2023
Q4 		$9.54M Sell
226,500
-68,200
-23% -$2.51M ﹤0.01% 2696
2023
Q3 		$11.3M Buy
294,700
+133,500
+83% +$3.02M ﹤0.01% 2392
2023
Q2 		$3.06M Buy
161,200
+44,500
+38% +$830K ﹤0.01% 4336
2023
Q1 		$1.81M Buy
116,700
+11,500
+11% +$200K ﹤0.01% 5356
2022
Q4 		$1.87M Buy
105,200
+10,100
+11% +$127K ﹤0.01% 4833
2022
Q3 		$531K Sell
95,100
-19,400
-17% -$94.8K ﹤0.01% 8325
2022
Q2 		$447K Buy
114,500
+3,000
+3% +$13K ﹤0.01% 8557
2022
Q1 		$614K Sell
111,500
-83,000
-43% -$517K ﹤0.01% 8414
2021
Q4 		$1.66M Sell
194,500
-240,600
-55% -$1.99M ﹤0.01% 5966
2021
Q3 		$3.78M Buy
435,100
+237,700
+120% +$2.14M ﹤0.01% 4463
2021
Q2 		$2.09M Buy
197,400
+168,000
+571% +$2.35M ﹤0.01% 5823
2021
Q1 		$472K Buy
+29,400
New +$775K ﹤0.01% 9615

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Susquehanna International Group's IMVT Position: Q1 2026 in Review

Susquehanna International Group increased its Immunovant (IMVT) stake by 138% in Q1 2026, buying an estimated $9.29M and bringing the position to 617,807 shares worth $15.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2539.

Susquehanna International Group first reported a position in IMVT in Q3 2020 and has held it in 23 quarters since. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Susquehanna International Group held 617,807 shares of Immunovant worth $15.3M as of Q1 2026.
  • Susquehanna International Group bought 358,690 Immunovant shares in Q1 2026, an estimated $9.29M.
  • Immunovant made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2539 holding.
  • Susquehanna International Group first reported a position in Immunovant in Q3 2020 and has held it in 23 quarters since.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.